Is Ivabradine Hydrochloride Tablet (Corlanor) in shortage?
Ivabradine Hydrochloride Tablet is listed by FDA as being discontinued by at least one maker (updated Mar 24, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Corlanor, Tablet, eq. 5 mg base (NDC 55513-800-60)
Discontinuation of the manufacture of the drug product
Maker contact: 1-800-772-6436
- Corlanor, Tablet, eq. 7.5 mg base (NDC 55513-810-60)
Discontinuation of the manufacture of the drug product
Maker contact: 1-800-772-6436
FDA recalls of Ivabradine Hydrochloride
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Ivabradine Hydrochloride Tablet:
Other forms on FDA’s list
Ivabradine Hydrochloride Tablet shortage questions
Is Ivabradine Hydrochloride Tablet (Corlanor) in shortage?
Ivabradine Hydrochloride Tablet is listed by FDA as being discontinued by at least one maker (updated Mar 24, 2026).
What should I do if I can’t get Ivabradine Hydrochloride Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.